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Sir, 
We read with interest the study of Andraweera et al., published recently in Acta Obstetricia et 
Gynecologica Scandinavica [1], reporting a strong association between 
maternal FTO (rs9939609) genotype and the risk of miscarriage and recurrent pregnancy 
loss. Inspired by the report, we attempted to test a related hypothesis that 
the FTO polymorphism is associated with spontaneous abortions when tissue sample from 
aborted fetus is used instead of maternal DNA. Such an association would indirectly confirm 
the findings by Andraweera et al. [1]. 
 
We compared 457 tissue samples of spontaneous abortions during the first trimester (cases) 
with a general population sample of 6681 middle-aged adults (aged 45–69 years) used as 
controls [2]. All cases and controls were genotyped for the FTO rs17817449 polymorphism; 
this single nucleotide polymorphism is in almost complete linkage disequilibrium with 
neighboring rs9939609. No association between number of children and FTO genotype was 
detected among controls. 
 
The distribution of the FTO genotypes did not differ between the cases and controls. The 
frequencies for GG vs. GT vs. TT alleles were 19.9% vs. 46.8% vs. 33.3% in cases and 
19.3% vs. 47.7% vs. 32.9% among controls (P = 0.92). The odds ratio for GG vs. GT/TT 
carriers was 1.04 (95% CI 0.82–1.32; P = 0.75). 
 
The FTO gene was first identified by a genome-wide association study as an independent 
genetic risk factor for obesity [3]; more recently, the polymorphism has also been implicated 
in other conditions, such as diabetes mellitus, myocardial infarction, renal failure or cancer. 
However, the exact biological role of the FTO gene remains unclear [4]. The gene is involved 
in demethylation of nucleic acids. As the correct fetal development is based on the DNA-
methylation-based programming, in theory the FTO gene is a promising candidate gene for 
predisposition to spontaneous abortion. The potential role of FTO in fetal development is 
further supported by the finding that in humans,FTO is highly expressed in placenta and its 
expression appears to correlate with increased fetal weight and length [5]. 
 
The fact that our study did not find any difference in FTO genotype between spontaneous 
abortions and healthy adults may be due to at least two reasons. First, the geographical 
localization and ethnic composition of our study sample differs from that in the study by 
Andraweera et al. [1]. Second, there was a major difference in the selection of cases between 
the studies. Our study has focused on analysis of aborted fetal tissues, not on females with 
experience of pregnancy loss. It is possible that the methylation status and subsequent fetal 
development depends on the genetic characteristics/FTO variant of females with a history of 
recurrent pregnancy loss, rather than on characteristics of the fetus. On the other hand, one 
would expect that even if the main risk factor is maternal genotype it would be detected in 
studies using fetal DNA (as it reflects the genotype inherited from the mother). Further 
studies are needed to confirm or refute the putative association between the FTO and 
recurrent miscarriage. 
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